David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
“Vital Plasma Derived Medicines: The Anomalous UK Scene
In the context of recent news of the renewed availability of plasma from UK citizens, and former UK residents, for pharmaceutical use in vital medicines production, this reminder may be apposite.
Unlike other National Regulators, the UK Authority, the MHRA, is apparently still haunted by phantom fears of the 20th Century Mad Cow Disease – leading it to maintain its utterly unwarranted prohibition of the use of UK donors’ plasma for the manufacture of a dozen or so vital medicines for which it is a perfectly suitable raw material.
This misguided behaviour is not only enforcing a most unfortunate waste of precious components of UK donors’ plasma – and costing the NHS money in the passing – it is also exacerbating severe global shortages of many of these life-saving medicines.
We UK donors may well ask – ‘why?’
Indeed, some of us have been asking this question for some years now.
Answer comes there none …
What do other donors and fellow LinkedIners think about this ?”

Find more posts featuring David McIntosh on Hemostasis Today.
-
Jul 14, 2026, 12:08Elvira Grandone: Finding the Right LMWH Dose for Pregnant Patients Suffering From DVT
-
Jul 14, 2026, 12:05Eloïse Laouenan: From Washington to Paris – Join GETBO at ISTH 2026
-
Jul 14, 2026, 12:02Louise St. Germain Bannon: Our first ISTH regulatory session at ISTH 2026
-
Jul 14, 2026, 11:21Malwina Maliszewska: Advancing Coagulation Diagnostics at ISTH 2026
-
Jul 14, 2026, 11:07Mary Cushman: Honoring Outstanding Mentorship at ISTH 2026
-
Jul 14, 2026, 10:53Maha Othman: Advancing the Management of Inherited Thrombocytopenias at ISTH 2026
-
Jul 14, 2026, 10:24Sara Zalghout: The Little Things That Make ISTH 2026 Special
-
Jul 14, 2026, 10:11Joseph R. Shaw: GAUGE Advances FXa Inhibitor Reversal at ISTH 2026
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation